Learning and knowledge sharing are fundamental to the LHSS Project. We invite you to search LHSS knowledge products and resources for the latest approaches, insights, and learning in the field of integrated health systems strengthening.
The video captures the significant sharing of a young student with HIV who was recently treated by a community-led social enterprise (The Niem Tin Song Tien social enterprise) participating in the current social contracting pilot in Vietnam.
The USAID Health System Sustainability Activity in Timor-Leste continues to support the Ministry of Health in strengthening the existing community health system and expanding the CBM-Health approach to additional villages.
This video captures Timor-Leste’s progress in increasing COVID-19 vaccination coverage and strengthening the capacity of health care professionals – efforts supported by LHSS’s local NGO partner HAMNASA.
2022 marked Vietnam's 10-year journey to sustain its HIV response with domestic financing (2013 – 2022). The country now stands out as a global example for sustainability and domestic resource mobilization for its HIV program.
USAID's Health System Sustainability Activity in Timor-Leste announced an additional funding of $600,000 to support the efforts of the Ministry of Health, Government of Timor-Leste, in fighting the COVID-19 pandemic.
This video captures a November 6, 2020 ceremony in Hanoi which marked the formal start of the LHSS Project’s four-year effort to help the Government of Vietnam implement its social health insurance program. The program covers treatment services for people with HIV, among other essential health services.
Working closely with the Vietnam Social Security (VSS) agency, LHSS will help improve the agency’s capacity to manage the insurance program funds effectively, efficiently, equitably, and with accountability. LHSS will also support Vietnam’s transition to full financial ownership of its HIV and TB responses.
HMED software will improve Vietnam’s capacity to effectively forecast ARV demand, and manage the drugs when they are in the country. Also, engaging drug manufacturers and distributors is crucial to overcoming supply side obstacles.